Literature DB >> 31190801

Mycosynthesis, characterization, anticancer and antibacterial activity of silver nanoparticles from endophytic fungus Talaromyces purpureogenus.

Xiaowen Hu1, Kandasamy Saravanakumar1, Tieyan Jin2, Myeong-Hyeon Wang1.   

Abstract

Background: Biogenic silver nanoparticles (AgNPs) have wider range of biomedical applications. The present work synthesized Tp-AgNPs using mycelial extract of endophytic fungus Talaromyces purpureogenus (MEEF), characterized, and analyzed for antibacterial, anti-proliferation and cell wounding healing activities.
Methods: The synthesized Tp-AgNPs were characterized by UV-visible spectrophotometer (UV-Vis), field emission transmission electron microscopy (FETEM) with energy-dispersive X-ray spectroscopy (EDS), Fourier transform infrared spectroscopy (FTIR), particle size analysis (PSA) and X-ray diffraction (XRD). Further, antibacterial activity was determined by Kirby-Bauer test and anti-proliferation activity was tested in human lung carcinoma A549 by water-soluble tetrazolium and flow cytometer assay. In addition, cell wounding healing activity was determined by scratch assay.
Results: UV-Vis results displayed a strong absorption peak from 390 nm to 420 nm, which indicated the successful synthesis of Tp-AgNPs. FETEM-EDS results indicated the round and triangle shaped Tp-AgNPs with the average size of 25 nm in accordance with PSA. FTIR analysis indicated the involvement of various functional molecules from MEEF in the synthesis of Tp-AgNPs. XRD result proved nature of Tp-AgNPs as a high-quality crystal. The Tp-AgNPs significantly inhibited the growth of bacterial pathogens at the minimal inhibitory concentration of 16.12 μg.mL-1 for Gram+, and 13.98 μg.mL-1 for Gram- bacteria. Further, Tp-AgNPs (2 μg.mL-1) showed a strong anti-proliferation effect in A549. Interestingly, Tp-AgNPs was not cytotoxic to normal NIH3T3 cells. In addition, the NPs exhibited a strong cell wounding healing activity.
Conclusion: This work biosynthesized AgNPs with strong antibacterial, anticancer and cell wound healing properties using endophytic fungus T. purpureogenus.

Entities:  

Keywords:  Talaromyces purpureogenus; antibacterial; anticancer; cell wound healing; mycosynthesis; silver nanoparticles

Mesh:

Substances:

Year:  2019        PMID: 31190801      PMCID: PMC6515543          DOI: 10.2147/IJN.S200817

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


Introduction

Nanotechnology provides a tool for synthesis of nanoparticles (NPs), which has an important role of applications in the field of biology, chemistry, physics, and medicine. In biology, NPs are mainly used as carriers to form green nanoparticles with various organisms, such as the use of silver nanoparticles (AgNP) conjugated with ceftriaxone to enhance the antibacterial properties of ceftriaxone. The green synthesis of AgNPs marine alga Gelidium amansii and bacterium Bacillus brevis has been reported to effectively fight against pathogens.3,4 In physics, many researchers use metal NPs as a special material to make nanoparticle sensors and nanoparticle switches.5–9 The United States, the European Union, and Japan accord great importance to the research on nanomedicine. The most important factor is a selection of metals for synthesizing of NPs. After more than two decades of research, the scientists have reported that the metals such as gold, silver, zinc, iron, copper, and platinum could be a potential source for the synthesis of nanomaterials. Among them, the silver has been used as a traditional disinfectant and antibacterial agent since ancient times, which has attracted the interest of more workers. AgNPs are also stable in physicochemical properties, including catalytic, antibacterial activity, and cytotoxicity to cancer cells. The “battle” between humans and pathogens has been going on for centuries, and a large number of human deaths have occurred due to pathogenic bacteria. Although after the discovery of the first antibioticpenicillin”, a phased victory has been achieved to combat diseases. However, with the massive abuse of antibiotics, the pathogens have evolved and developed resistance genes thereby resulting in resistance toward available antibiotics. Therefore, research is imminent to search for alternatives antibiotics.14,15 To achieve this goal, researchers are in focus of Ag+ that has a strong antibacterial ability through increased contact with pathogenic bacteria. Cancer has become the second leading cause of death in the world, and about 9.55 million people died of cancer so far in 2018. Among 7.6 billion people in the world, about 18 million people have cancer incidence, of which, lung cancer patients account for 11.6% as ranking first. The human lung cancer cells A459 belong to human lung alveolar basal epithelial cells are currently used as a model for lung cancer and anti-lung cancer drug research. The treatment of cancer cells through surgery, radiotherapy, and traditional chemotherapy are cytotoxic to normal cells and these methods are expensive, and ineffective.19– In order to reduce the cytotoxicity and improve the efficiency of the chemotherapy, the synthesis of unique nanocomposites combined with anti-cancer drugs is attempted. The anticancer activity of AgNPs is proved in many experiments.23–26 However, chemically synthesized AgNPs are cytotoxic to normal human cells. Therefore, in recent years, biosynthesized AgNPs is in much focus of the researchers. Endophytic fungi are beneficial endosymbiont not causing any disease in plants. The endophytic fungi are a good source of antibacterial and anti-cancer drugs, as evident by the first discovery of “Pseudomycin”. In recent years, the endophytic fungi based biosynthesis NPs are favored due to their economical, environmental friendly and stable characteristics. Compared with plants and other microorganisms, endophytic fungi are good machines for the synthesis of any type of metallic NPs because of amenability to culture conditions, extracellular enzyme secretion, rapid growth, easy production of biomass and simple operation of the endophytic fungi. In the present study, we used an endophytic fungus T. purpureogenus isolated from leaves of Pinus densiflora for the synthesis of AgNPs, which were further characterized and evaluated for cell viability, antibacterial, and wound healing activities.

Materials and methods

Microorganisms and chemicals

The endophytic fungal strain T. purpureogenus (GenBank accession number: MK108915) was used for the synthesis of NPs. This fungal strain was previously isolated from the leaves of Pinus densiflora S. et Z. collected from the mountain of Kangwon National University, Chuncheon. Bacterial pathogens such as Staphylococcus aureus (ATCC13150), Bacillus cereus (KNIH28), Salmonella enterica (ATCC14028), Pseudomonas aeruginosa (ATCC27853), and Escherichia coli (ATCC27853) were used for the antibacterial assay. The chemicals including tartaric acid, silver nitrate (AgNO3, 99.8%, Sigma, St Louis, MO, USA), water-soluble tetrazolium (WST)-1 assay kit (EZ-Cytox; Daeil Lab Service, Republic of Korea), the PBS, Roswell Park Memorial Institute medium (RPMI-1640), DMEM, FBS and Penicillin-Streptomycin (P/S) from Gibco (Waltham, MA, USA), and all chemicals were obtained from local chemical vendor, Seoul, Republic of Korea. The human lung carcinoma, A549 cell line (KCLB-10,185) and the Swiss albino mouse embryo tissue, NIH3T3 cell line was obtained from the Korean Cell Line Bank (KCLB, Seoul, Republic of Korea). The A549 cell line cultured in RPMI-1640 and the NIH3T3 cell line cultured in DMEM, both kinds of medium containing 10% FBS and 1% PS at 37°C in a 5% CO2 humidified incubator for 24 hrs to achieve 80–90% confluent followed by preservation in Cell Freezing Media (DMSO, BCS) in liquid nitrogen in a cryogenic vial for the experimental use.

Preparation of endophytic fungal extracts

The MEEF (mycelial extract of endophytic fungi) was prepared following standard methods.29–31 In brief, 2 mL of fungal spore suspension (8 × 106spores/mL) was inoculated in 200 mL PDB in 500 mL Erlenmeyer flasks incubated at 27±2°C for 72 hrs with continuous shaking at 180 rpm. After incubation periods, the residual components of the medium in the mycelia were separated by filtration followed by washing with distilled water three times. Finally, the harvested wet fungal biomass (20–30 g) was transferred into 100 mL distilled water in 250 mL Erlenmeyer flasks and incubated at 27±2°C for 24 hrs with 180 rpm shaking for the extraction. At the end shaking process, cell-free filtrate (MEEF) was filtered using Whatman No.1 filter paper and used in further experiments.

Biosynthesis of Tp-AgNPs

The AgNPs were synthesized according to the method32 with modifications. In brief, the synthesis of the Tp-AgNPs was initiated by adding 30 mM AgNO3 in 100 mL of MEEF and the reaction mixture was incubated in shaking incubator at 27°C for 96 hrs with 180 rpm in dark. The aliquots of samples were withdrawn at different time intervals and observed for color change from white to dark brown.

Characterization of biosynthesized silver nanoparticles

The successful synthesis of Tp-AgNPs was determined by measuring the absorbance of the solution at different time intervals (1, 4, 12, 24, 48, and 96 hrs) at 300–700 nm (1 nm interval) using UV–Vis spectrophotometer (Libra S80; Biochrom Ltd, UK). After the 96 hrs reaction, the mixture was centrifuged at 12,000 rpm at room temperature for 15 mins, the supernatant was discarded, and washed by distilled water. Then, Tp-AgNPs were lyophilized and this lyophilized powder was used for further characterization using Fourier transform infrared spectroscopy (FTIR) (Frontier; PerkinElmer, Waltham, MA, USA) to detect the molecular structure and chemical bonds. The Tp-AgNPs powder was suspended in ethanol to determine the size and shape using field emission transmission electron microscopy (FETEM)–energy-dispersive X-ray spectroscopy (EDS) (JEM-2100F; Jeol, Tokyo, Japan). The size of Tp-AgNPs was determined by particle size analyzer (PSA) (model Mastersizer 3000; Malvern Instruments, Malvern, UK). Finally, X-ray diffraction (XRD) (X’Pert PRO MPD; PANalytical, Almelo, the Netherlands) was used to analyze the morphology and crystalline nature of Tp-AgNPs in a wide range of Bragg angles 2ᶿ at scanning rate 30°–80° at 0.041°/mins with a time constant of 2 s. The dielectric contents were calculated and used to study the optical properties of Tp-AgNPs as described elsewhere33,34

Cell viability

The cell viability was determined by WST kit assay. The A459 cells were cultured in RPMI medium incorporated with 1% P/S antibiotics, 10% FBS in 5% CO2 incubator at 37°C. After reaching the 80–90% confluence, the healthy cells were washed with PBS and then collected using Trypsin-EDTA. The 100 μL of healthy A549 cells (1 x 104 cells.mL−1) were seeded in 96-well plate and incubated in a CO2 incubator for 24 hrs at 37°C in 5% CO2 incubator. After incubation, the cells were checked under the microscope to confirm the proliferation of the cells at the level of 80–90% confluence, then 10 μL different concentrations of Tp-AgNPs (0–1000 μg.mL−1) were added to wells at triplicate and the cells were allowed to react with Tp-AgNPs in CO2 incubator for 24 hrs. Then, the cytotoxicity of the Tp-AgNPs was measured by adding the 10 μL of EZ-Cytox to each well and incubated in a CO2 incubator for 1 hrs. Finally, the samples were gently shaken for 1 min and measured the absorbance at 450 nm using a plate reader (Libra S80; Biochrom Ltd.) for calculating cell viability (%). For the flow cytometer analysis, the IC50 concentration of the Tp-AgNPs was treated to A549 cells in 5% CO2 incubator at 37°C for 48 hrs. Then, using Trypsin-EDTA the treated and untreated cells were harvested and washed by PBS to remove the Trypsin-EDTA by centrifugation. The washed cells were collected by centrifuge and dissolved in 100 μL of 1X annexin-binding buffer. For the flow cytometer reading, 5 μL of FITC annexin V and 1 μL of PI (100 μL/mL) were added to 100 μL of A549 cell suspension. This mixture was incubated at room temperature for 15 mins. Finally, 400 μL of 1X annexin-binding buffer was added and gently mixed. The stained cells were analyzed by flow cytometry, measuring the fluorescence emission at 530 nm (eg, FL1) and >575 nm (eg, FL3).

Antibacterial

The disc diffusion method was used to determine the antibacterial activity of Tp-AgNPs according to the method described elsewhere. In brief, all the bacterial strains (S. aureus, B.cereus, S.enterica, P.aeruginosa, and E.coli) were cultured in 10 mL of MHB in 50 mL Erlenmeyer flask for overnight at 37°C. Then, 50 μL of grown bacterial cell suspensions was spreading on MHA plates. Further, the 5 mm of sterile discs saturated with either antibiotics (positive control group) and/or different concentrations of Tp-AgNPs were placed on each plate and incubated at 37°C for 24 hrs. The antibacterial activity of Tp-AgNPs was measured as clear zone inhibition (mm) using a vernier caliper.

Cell wound healing

The NIH3T3 cells (1 x 105 mL−1) were cultured in 2 mL/well of DMEM supplement with 10% FBS and 1% P/S in 6-well plate, incubated in 5% CO2 incubator at 37°C for 24 hrs. Meanwhile, different concentrations of Tp-AgNPs solution was prepared using DMEM. After incubation, the cell confluence was checked under microscope and the cells were scratched using the pipette tips, then washed with PBS. The control was replaced with normal DMEM for control, while the test group was replaced with different concentrations of Tp-AgNPs incorporated DMEM. The wound healing area was calculated at different time intervals (0–48 hrs) using a microscope and ImageJ software.

Result and discussion

In the process of biosynthesis of Tp-AgNPs, the original white reaction mixture (MEEF and AgNO3) was gradually turned into brown, and the color became deeper (Figure 1A). The Tp-AgNPs was irradiated with light, for an electronic dipole oscillation phenomenon to occur.37–39 The strong absorption peak in the wavelength range from 390 to 420 nm with a distinct peak at around 418 nm (Figure 1A) from UV-Vis analysis indicated the successful synthesis of Tp-AgNPs in accordance with previous reports.
Figure 1

. Synthesis of the Tp-AgNPs using the endophytic fungi extracts and their characterization by UV-visible spectrophotometer (A), FTIR analysis (B), Particle size analysis (C), XRD pattern analysis (D).

Abbreviations: FTIR, Fourier transform infrared spectroscopy; XRD, X-ray diffraction; Tp-AgNPs, Talaromyces purpureogenus silver nanoparticles.

. Synthesis of the Tp-AgNPs using the endophytic fungi extracts and their characterization by UV-visible spectrophotometer (A), FTIR analysis (B), Particle size analysis (C), XRD pattern analysis (D). Abbreviations: FTIR, Fourier transform infrared spectroscopy; XRD, X-ray diffraction; Tp-AgNPsTalaromyces purpureogenus silver nanoparticles. FTIR analysis provides information about the functional groups, involved in the synthesis and/or stabilizing of Tp-AgNPs. FTIR spectrum of Tp-AgNPs (Figure 1B) showed the peak at 3260 cm−1 (O–H and N–H), 2923 cm−1 (C in C–H), 1628 cm−1 and 1554 cm−1 corresponding to the stretching vibration of the C=C, 1371 cm−1 corresponding to the expansion and contraction of C–O and C–X, 1024 cm−1 corresponding to the stretching vibration of C–O in the alcohol. Overall, the FTIR analysis indicated the presence of functional groups such as benzene rings, amines, and alcohols in Tp-AgNPs. The comparison of FTIR spectrum of Tp-AgNP with MEEF indicated that many of the peaks in the range of 900–500 cm−1 were corresponding to C-substitution stretching vibration at different positions on the benzene ring. So, biosynthesis of the NPs retained only the main functional groups of the fungus, similar to the earlier reports. The average size of the Tp-AgNPs was about 25 nm, as evident by PSA (Figure 1C). In addition, the XRD analysis indicated the 2θ values of 46° which is corresponding to Braggs’s refraction value (220), and it is similar to earlier XRD report of the biosynthesized AgNPs.42–44 Also, the present results compared with the general AgNPs, the 2θ value obtained in this experiment was similar at the peak of 46° belonging to the characteristic peak of AgNPs (Figure 1D). Most of the Tp-AgNPs were dispersed, round, triangles shaped and sized <50 nm (Figure 2A,B), as revealed by TEM-EDS. The EDS analysis confirmed the presence of 38.15% of Ag atoms (Figure 2C–E).
Figure 2

FETEM image of Tp-AgNPs at <100 nm (A) and 20 nm (B). EDS-based mapping of the Ag (C) and carbon in Tp-AgNPs (D). EDS chromatograph of Tp-AgNPs (E).

Abbreviations: FETEM, field emission transmission electron microscopy; Tp-AgNPs, Talaromyces purpureogenus silver nanoparticles; EDS, energy-dispersive X-ray spectroscopy; Ag, silver.

FETEM image of Tp-AgNPs at <100 nm (A) and 20 nm (B). EDS-based mapping of the Ag (C) and carbon in Tp-AgNPs (D). EDS chromatograph of Tp-AgNPs (E). Abbreviations: FETEM, field emission transmission electron microscopy; Tp-AgNPsTalaromyces purpureogenus silver nanoparticles; EDS, energy-dispersive X-ray spectroscopy; Ag, silver. The Tp-AgNPs showed cytotoxicity in A549 cells even at the lowest concentration of 2 μg/mL, and the cytotoxicity was also increased with the increase of NPs concentration (Figure 3A). Moreover, AgNO3 showed higher cytotoxicity than the Tp-AgNPs. Further, the calculated IC50 for AgNPs and AgNO3 was 376.24 and 250.31 μg/mL, respectively. According to the results of cell flow cytometer, 5.92% of cell apoptosis was induced by Tp-AgNPs (Figure 3B,C). Similarly, AgNPs are known to induce cytotoxicity on various cancer cells rat alveolar macrophages, HepG2, A549, SGC-7901, MCF7, HeLa, U937, RAW 264.7, L929, A431, HIV virus. Moreover, the cytotoxicity of the AgNPs depends on size, surface area, internalization and attachment efficiency. Smaller size of the AgNPs with smaller size can be able to internalize in the mammalian cells and cause the cytotoxicity through ROS generation, nucleus damage, activation of the apoptosis or mitochondrial pathways. The potential cytotoxicity of Tp-AgNPs is attributed to smaller size of <50 nm in Tp-AgNPS, which not only reflected the cytotoxicity but also reflected in excellent anti-cancer activity.
Figure 3

Cytotoxicity of Tp-AgNPs and AgNO3 in A549 cells (A). Flow cytometry-based analysis of cell death in A549 cells untreated (B) and treated with Tp-AgNPs (C) and analysis of the ROS generation in A549 cells untreated (E) and treated with Tp-AgNPs (D).

Abbreviations: CK, control group; Tp-AgNPs, Talaromyces purpureogenus silver nanoparticles; AgNO3, silver nitrate; ROS, reactive oxygen species. 

Cytotoxicity of Tp-AgNPs and AgNO3 in A549 cells (A). Flow cytometry-based analysis of cell death in A549 cells untreated (B) and treated with Tp-AgNPs (C) and analysis of the ROS generation in A549 cells untreated (E) and treated with Tp-AgNPs (D). Abbreviations: CK, control group; Tp-AgNPsTalaromyces purpureogenus silver nanoparticles; AgNO3, silver nitrate; ROS, reactive oxygen species. The Tp-AgNPs showed different degrees of antibacterial activity with increase in concentration (Figure 4).  Our results on potent antibacterial activity of AgNPs are in accordance with earlier reports, as shown in Table 1. Tp-AgNPs significantly inhibited the growth of Gram-positive or Gram-negative pathogens at the minimal inhibitory concentration of 16.12 μg.mL−1, and 13.98 μg.mL−1, respectively. Moreover, Tp-AgNPs showed higher zone of inhibition against S. aureus (9 mm), P. aeruginosa (13 mm) and E. coli (11 mm) and it is similar to positive antibiotic control vancomycin (Table 2). TP-AgNPs did not show such a strong antibacterial effect on B. cereus (11 mm) and S. enterica (11 mm), which is similar to an antibiotic (Table 2).
Figure 4

Antibactrial activity of Tp-AgNPs: Staphylococcus aureus (A), Bcillus cereus (B), Salmonella entrica (C), Pseudomonas aeruginosa (D), and Escherichia coli (E). Ab – vancomycin; different concentrations of Tp-AgNPs solution: 25–100 µg mL−1.

Abbreviations: Tp-AgNPs, Talaromyces purpureogenus silver nanoparticles; Ab, vancomycin.

Table 1

Antibacterial activity of silver nanoparticles (AgNPs) synthesized by endophytic fungi

No.Name of host plantName of endophytic fungiAgNPs size (nm)ApplicationReference
1Solanum nigrumSetosphaeria sp.20–50Antibacterial49
2Solanum lycopersicum L.Aspergillus terreus45.2Antifungal50
3Salacia chinensisPhomopsis liquidambaris18.7Antimicrobial and larvicidal activity51
4Taxus baccata L.Nemania sp.33.52Antibacterial52
5Chetomorpha antenninaPenicilliumpolonicum ARA 1010–15Antibacterial53
6Withania SomniferaFusarium semitectumAntibacterial54
7Simarouba glaucaAspergillus niger41.9AntibacterialAntioxidantAntimitotic55
8Calotropis proceraAspergillus terreus16.45Antibacterial56
9Chetomorpha antenninaPenicillium polonicum10–15Antibacterial57
10Arctostaphylos uva-ursi,Anabasis articulate,MenthaCornulacaAlternaria arborescensAlternaria alternataAlternaria brassicaeNigrospora oryzaePenicillium crustosum5–20Antimicrobial58
11Tectona grandisChaetomium globosum16Antibacterial59
12orchids,Dendrobium nobile,Dendrobium hibiki,Oncidium altissimumKDH5VDN3B15–25Antibacterial60
13Raphanus sativusAlternaria sp10–30Antibacterial61
14Glycosmis mauritianaPenicillium65AntioxidantAntibacterial62
15Psidium guajava Linn.Pestaloptiopsis pauciseta123–195Unknown63
16CatharanthusroeusCurvularia lunata26Antimicrobial64
17Centella asiatica Aspergillus niger10–50Antimicrobial65
18Potentilla fulgens L.Aspergillus tamari PFL2,Aspergillus niger PFR6Penicllium ochrochloron PFR8.3.58.77.7Unknown66
19Curcuma longaPenicillium sp.25–30Antibacterial67
20Rhizophora mangleLaguncularia racemosaMGE-201L-2–235AntifungalAntibacterial68
21Pinus densiflora S. et Z.Talaromyces purpureogenus<50AntibacterialPresent study
Table 2

Zone of inhibition of produced by Tp-AgNPs synthesized from endophytic fungi Talaromyces purpureogenus against bacterial pathogens

Pathogenic bacterial strainsZone of inhibition (mm)
Vancomycin (5 μg/mL)Silver nanoparticles (Tp-AgNPs)
25 μg/mL50 μg/mL75 μg/mL100 μg/mL
S. aureus96789
B.cereus22891011
S. enterica20899.511
P. aeruginosa157.5810.513
E. coli888.59.511

Abbreviations: Tp-AgNPs, Talaromyces purpureogenus silver nanoparticles; S.aureus, Staphylococcus ; B.cereus, Bcillus cereus; S.enterica, Salmonella entrica; P.aeruginosa, Pseudomonas aeruginosa;E.coli, Escherichia coli.

Antibacterial activity of silver nanoparticles (AgNPs) synthesized by endophytic fungi Zone of inhibition of produced by Tp-AgNPs synthesized from endophytic fungi Talaromyces purpureogenus against bacterial pathogens Abbreviations: Tp-AgNPsTalaromyces purpureogenus silver nanoparticles; S.aureus, Staphylococcus ; B.cereus, Bcillus cereus; S.enterica, Salmonella entrica; P.aeruginosa, Pseudomonas aeruginosa;E.coliEscherichia coli. Antibactrial activity of Tp-AgNPs: Staphylococcus aureus (A), Bcillus cereus (B), Salmonella entrica (C), Pseudomonas aeruginosa (D), and Escherichia coli (E). Ab – vancomycin; different concentrations of Tp-AgNPs solution: 25–100 µg mL−1. Abbreviations: Tp-AgNPsTalaromyces purpureogenus silver nanoparticles; Ab, vancomycin. Microscopic analysis revealed that the wound area decreased with the treatment of Tp-AgNPs as compared to the untreated control group after 48 hrs. The wound scratch distance of treated group was relatively small (Figure 5). The wound area decreased with the dose-dependent manner. For example, the wound area was 1.976, 1.824, and 1.4364 cm2, respectively, at different concentrations (1, 5 and 10 μg/mL) of the experimental group. In addition, the wound area of treated group was smaller than the untreated control area (2.356 cm2) (Table 3). By comparing the cell growth rate for each time period, the growth rate of each treated group was significantly higher than that of the untreated control (Figure 6). Tp-AgNPs were not toxic to NIH3T3 normal cells.
Figure 5

Wound healing effect of the Tp-AgNPs in NIH3T3 cells at different time intervals.

Abbreviations: CK, control group; Tp-AgNPs, Talaromyces purpureogenus silver nanoparticles; NIH3T3, Swiss albino mouse embryo tissue.

Table 3

Cell wound healing efficiency of Tp-AgNPs

Concentration of Tp-AgNPs (μg/mL)Wound healing area (cm2)
0 hrs12 hrs24 hrs48 hrs
Untreated5.2443.83.792.356
15.4343.4872.8881.976
55.7764.183.421.824
106.1563.422.5461.436

Abbreviation: Tp-AgNPs, Talaromyces purpureogenus silver nanoparticles.

Figure 6

The growth rate of wound healing effort of the Tp-AgNPs in NIH3T3 cells at different time intervals.

Abbreviations: Tp-AgNPs, Talaromyces purpureogenus silver nanoparticles; NIH3T3, Swiss albino mouse embryo tissue.

Cell wound healing efficiency of Tp-AgNPs Abbreviation: Tp-AgNPsTalaromyces purpureogenus silver nanoparticles. Wound healing effect of the Tp-AgNPs in NIH3T3 cells at different time intervals. Abbreviations: CK, control group; Tp-AgNPsTalaromyces purpureogenus silver nanoparticles; NIH3T3, Swiss albino mouse embryo tissue. The growth rate of wound healing effort of the Tp-AgNPs in NIH3T3 cells at different time intervals. Abbreviations: Tp-AgNPsTalaromyces purpureogenus silver nanoparticles; NIH3T3, Swiss albino mouse embryo tissue.

Conclusion

In this study, we synthesized Tp-AgNPs using MEEF and they were characterized for is high-quality crystal particles with a size <50 nm. The NPs showed the concentration-dependent cytotoxicity against A549 and have a good inhibitory effect on various pathogenic bacteria. In addition, the NPs also showed the cell wound healing efficiency. Further focus will be on the molecular mechanism of anti-cancer and antibacterial properties of Tp-AgNPs.
  41 in total

1.  Coherent molecular resonances in quantum dot-metallic nanoparticle systems: coherent self-renormalization and structural effects.

Authors:  Ali Hatef; S M Sadeghi; Mahi R Singh
Journal:  Nanotechnology       Date:  2012-04-30       Impact factor: 3.874

2.  Rapid synthesis of silver nanoparticles using dried medicinal plant of basil.

Authors:  Naheed Ahmad; Seema Sharma; Md K Alam; V N Singh; S F Shamsi; B R Mehta; Anjum Fatma
Journal:  Colloids Surf B Biointerfaces       Date:  2010-07-24       Impact factor: 5.268

3.  Antibiotic activity of natural products: 1. Propolis.

Authors:  W Brumfitt; J M Hamilton-Miller; I Franklin
Journal:  Microbios       Date:  1990

4.  Nanoparticles in medicine: therapeutic applications and developments.

Authors:  L Zhang; F X Gu; J M Chan; A Z Wang; R S Langer; O C Farokhzad
Journal:  Clin Pharmacol Ther       Date:  2007-10-24       Impact factor: 6.875

5.  Biogenic antimicrobial silver nanoparticles produced by fungi.

Authors:  Alexandre G Rodrigues; Liu Yu Ping; Priscyla D Marcato; Oswaldo L Alves; Maria C P Silva; Rita C Ruiz; Itamar S Melo; Ljubica Tasic; Ana O De Souza
Journal:  Appl Microbiol Biotechnol       Date:  2012-06-16       Impact factor: 4.813

6.  Impact of silver nanoparticles on human cells: effect of particle size.

Authors:  Wei Liu; Yuan Wu; Chang Wang; Hong C Li; Thanh Wang; Chun Y Liao; Lin Cui; Qun F Zhou; Bing Yan; Gui B Jiang
Journal:  Nanotoxicology       Date:  2010-09       Impact factor: 5.913

Review 7.  Silver as antibacterial agent: ion, nanoparticle, and metal.

Authors:  Svitlana Chernousova; Matthias Epple
Journal:  Angew Chem Int Ed Engl       Date:  2012-12-17       Impact factor: 15.336

8.  Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species.

Authors:  C Carlson; S M Hussain; A M Schrand; L K Braydich-Stolle; K L Hess; R L Jones; J J Schlager
Journal:  J Phys Chem B       Date:  2008-10-03       Impact factor: 2.991

Review 9.  Biological synthesis of metallic nanoparticles.

Authors:  Kaushik N Thakkar; Snehit S Mhatre; Rasesh Y Parikh
Journal:  Nanomedicine       Date:  2009-07-16       Impact factor: 5.307

10.  Toxicity and antibacterial assessment of chitosan-coated silver nanoparticles on human pathogens and macrophage cells.

Authors:  Prajna Jena; Soumitra Mohanty; Rojee Mallick; Biju Jacob; Avinash Sonawane
Journal:  Int J Nanomedicine       Date:  2012-04-03
View more
  10 in total

1.  Mycosynthesis of Silver Nanoparticles by Candida albicans Yeast and its Biological Applications.

Authors:  R A Hikmet; N N Hussein
Journal:  Arch Razi Inst       Date:  2021-10-31

2.  Antioxidative, cytotoxic, and antibacterial properties of self-assembled glycine-histidine-based dipeptides with or without silver nanoparticles in bio-inspired film.

Authors:  Merve Eylul Kiymaci; Hakan Erdoğan; Merve Bacanlı
Journal:  Arh Hig Rada Toksikol       Date:  2022-07-07       Impact factor: 2.078

Review 3.  Silver nanoparticles: Synthesis, medical applications and biosafety.

Authors:  Li Xu; Yi-Yi Wang; Jie Huang; Chun-Yuan Chen; Zhen-Xing Wang; Hui Xie
Journal:  Theranostics       Date:  2020-07-11       Impact factor: 11.556

4.  Physicochemical properties, anticancer and antimicrobial activities of metallic nanoparticles green synthesized by Aspergillus kambarensis.

Authors:  Mohammadhassan Gholami-Shabani; Fattah Sotoodehnejadnematalahi; Masoomeh Shams-Ghahfarokhi; Ali Eslamifar; Mehdi Razzaghi-Abyaneh
Journal:  IET Nanobiotechnol       Date:  2021-11-23       Impact factor: 1.847

5.  Role of Biosynthesized Ag-NPs Using Aspergillus niger (MK503444.1) in Antimicrobial, Anti-Cancer and Anti-Angiogenic Activities.

Authors:  Akbar Pasha; Divya Vishambhar Kumbhakar; Siva Sankar Sana; Doneti Ravinder; B Vijaya Lakshmi; Suresh K Kalangi; Smita C Pawar
Journal:  Front Pharmacol       Date:  2022-01-25       Impact factor: 5.810

Review 6.  Recent Advances in Green Synthesis of Ag NPs for Extenuating Antimicrobial Resistance.

Authors:  Simerjeet Parmar; Harwinder Kaur; Jagpreet Singh; Avtar Singh Matharu; Seeram Ramakrishna; Mikhael Bechelany
Journal:  Nanomaterials (Basel)       Date:  2022-03-28       Impact factor: 5.076

Review 7.  Bio-Nanocarriers for Lung Cancer Management: Befriending the Barriers.

Authors:  Shruti Rawal; Mayur Patel
Journal:  Nanomicro Lett       Date:  2021-06-12

8.  Pleiotropic Functions and Biological Potentials of Silver Nanoparticles Synthesized by an Endophytic Fungus.

Authors:  Radhika Chandankere; Jayabaskaran Chelliah; Kamalraj Subban; Vanitha C Shanadrahalli; Amreesh Parvez; Hossain M Zabed; Yogesh C Sharma; Xianghui Qi
Journal:  Front Bioeng Biotechnol       Date:  2020-02-21

9.  Strong Antimicrobial Activity of Highly Stable Nanocomposite Containing AgNPs Based on Water-Soluble Triazole-Sulfonate Copolymer.

Authors:  Alexander Pozdnyakov; Artem Emel'yanov; Anastasiya Ivanova; Nadezhda Kuznetsova; Tat'yana Semenova; Yuliya Bolgova; Svetlana Korzhova; Olga Trofimova; Tat'yana Fadeeva; Galina Prozorova
Journal:  Pharmaceutics       Date:  2022-01-16       Impact factor: 6.321

Review 10.  Nanoparticles as therapeutic options for treating multidrug-resistant bacteria: research progress, challenges, and prospects.

Authors:  Ifeanyi E Mba; Emeka I Nweze
Journal:  World J Microbiol Biotechnol       Date:  2021-05-28       Impact factor: 3.312

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.